The merger has closed and the stock is deregistered. Existing shareholders should have received merger consideration per the April 14, 2026 agreement. No further public trading or SEC filings are expected. Monitor for any post-merger corporate actions from the parent entity.
Price Chart
Executive Summary
Galera Therapeutics filed a Form 15-12G to terminate registration of its common stock under Section 12(g) following its acquisition by Gazelle Parent, Inc. The merger closed on August 3, 2026, and Galera became a wholly-owned subsidiary, resulting in only one holder of record. This deregistration is a routine procedural step post-merger, ending Galera's SEC reporting obligations and public market presence.
Key Facts
- Form 15-12G filed August 4, 2026 to terminate registration under Section 12(g).
- Effective August 3, 2026, Merger Sub 2 merged into Galera, making it a wholly-owned subsidiary of Gazelle Parent, Inc.
- Only one holder of record exists as of the filing date.
- The merger was pursuant to an Agreement and Plan of Merger dated April 14, 2026.
- Galera no longer has a duty to file periodic reports with the SEC.
Financial Impact
Not specified
Risk Factors
- Loss of public market liquidity — shares will no longer trade on any exchange.
- No ongoing SEC reporting reduces transparency for remaining security holders.
- Potential for delayed or disputed merger consideration distribution.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 15-12G Filing (Primary) | 0001193125-26-332816 |
| Document: 0001193125-26-332816-index-headers.html | 0001193125-26-332816 |
| Document: 0001193125-26-332816-index.html | 0001193125-26-332816 |
| Document: 0001193125-26-332816.txt | 0001193125-26-332816 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 10, 2026 11w ago | EFFECT | — | awaiting T+20 | — | — |
Aug 4, 2026 12w ago | 15-12G | — | awaiting T+20 | — | — |
Aug 3, 2026 12w ago | 8-K | — | awaiting T+20 | — | — |
Jul 13, 2026 15w ago | 8-K | $16.39 | awaiting T+20 | — | — |
Jul 7, 2026 16w ago | 8-K | $17.80 | awaiting T+20 | — | — |
May 21, 2026 22w ago | 425 | $0.1000 $0.0910 | ▼ −9.00% | ▼ −7.58% | — |
May 19, 2026 23w ago | 8-K | $0.1010 $0.0857 | ▲ +15.15% | ▲ +15.89% | — |
Apr 22, 2026 26w ago | 425 | $20.00 $20.20 | ▲ +1.00% | ▼ −3.22% | — |
Apr 22, 2026 26w ago | 425 | $20.00 $20.20 | ▲ +1.00% | ▼ −3.22% | — |
Apr 14, 2026 28w ago | Press Release | $0.0790 $0.1000 | ▼ −26.58% | ▼ −20.29% | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers